Filana Therapeutics, Inc. Total Liabilities and Equity
Filana Therapeutics, Inc. (FLNA) had Total Liabilities and Equity of $108.37 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-05-07
- 2026-03-31: Liabilities and Equity $108.37M.
- 2025-12-31: Liabilities and Equity $118.36M.
- 2025-09-30: Liabilities and Equity $129.73M.
- 2025-06-30: Liabilities and Equity $135.38M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-03-31 | $108.37M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $118.36M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $129.73M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $135.38M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $140.93M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $157.53M 10-K · filed 2026-03-12 |
| 2024-09-30 | $223.75M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $243.57M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $155.72M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $151.66M 10-K · filed 2025-03-03 |
| 2023-09-30 | $172.53M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $197.25M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $218.11M 10-Q · filed 2023-05-01 |
| 2022-12-31 | $234.83M 10-K · filed 2024-02-28 |
| 2022-09-30 | $207.29M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $227.38M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $244.19M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $266.78M 10-K · filed 2023-02-28 |
| 2021-09-30 | $274.25M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $281.31M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $284.05M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $94.30M 10-K · filed 2022-03-01 |
| 2020-09-30 | $25.40M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $25.50M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $25.98M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $23.49M 10-K · filed 2021-03-23 |
| 2019-09-30 | $18.38M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $18.80M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $19.52M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $20.14M 10-K · filed 2020-03-26 |
| 2018-09-30 | $20.84M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $9.83M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $11.06M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $10.83M 10-K · filed 2019-03-29 |
| 2017-09-30 | $12.38M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $14.27M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $17.60M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $19.30M 10-K · filed 2018-02-06 |
| 2016-09-30 | $22.48M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $24.94M 10-Q · filed 2016-07-19 |
| 2016-03-31 | $28.63M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $31.92M 10-K · filed 2017-03-07 |
| 2015-09-30 | $35.65M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $37.76M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $39.63M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $40.91M 10-K · filed 2016-03-03 |
| 2014-09-30 | $43.59M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $45.39M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $47.32M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $50.10M 10-K · filed 2015-02-18 |
| 2013-09-30 | $51.76M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $53.20M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $54.87M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $56.86M 10-K · filed 2014-02-05 |
| 2012-09-30 | $93.26M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $94.44M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $96.81M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $98.96M 10-K · filed 2013-02-08 |
| 2011-09-30 | $100.59M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $102.59M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $99.19M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |